IRIS
BELLOCCHI, MARIA CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.217
AS - Asia 1.448
EU - Europa 1.359
SA - Sud America 292
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 14.358
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.171
SG - Singapore 793
IT - Italia 345
BR - Brasile 251
CN - Cina 245
HK - Hong Kong 192
DE - Germania 177
SE - Svezia 124
UA - Ucraina 117
IE - Irlanda 111
RU - Federazione Russa 98
PL - Polonia 92
FR - Francia 87
GB - Regno Unito 64
VN - Vietnam 64
FI - Finlandia 52
KR - Corea 37
NL - Olanda 26
CA - Canada 25
IN - India 24
ID - Indonesia 20
AR - Argentina 18
MX - Messico 18
BE - Belgio 17
AT - Austria 15
CZ - Repubblica Ceca 14
JP - Giappone 13
BD - Bangladesh 10
ES - Italia 9
ZA - Sudafrica 9
UZ - Uzbekistan 8
TR - Turchia 7
EC - Ecuador 6
CL - Cile 4
EG - Egitto 4
IL - Israele 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
CO - Colombia 3
IQ - Iraq 3
IR - Iran 3
KE - Kenya 3
KZ - Kazakistan 3
PH - Filippine 3
PK - Pakistan 3
SC - Seychelles 3
VE - Venezuela 3
AU - Australia 2
CM - Camerun 2
DK - Danimarca 2
ET - Etiopia 2
EU - Europa 2
JO - Giordania 2
MN - Mongolia 2
MY - Malesia 2
NP - Nepal 2
PY - Paraguay 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BW - Botswana 1
CD - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
PA - Panama 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 14.358
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.879
Wilmington 2.720
Houston 2.443
Singapore 442
Fairfield 413
Chandler 277
Ashburn 262
Ann Arbor 232
Hong Kong 192
Rome 185
Seattle 179
Beijing 149
Cambridge 136
Dublin 103
Jacksonville 98
Santa Clara 98
New York 97
Medford 83
Creede 69
Kraków 69
The Dalles 68
Los Angeles 62
Dearborn 45
Lawrence 37
Milan 37
Munich 35
Buffalo 34
Dallas 34
San Diego 26
São Paulo 26
Ho Chi Minh City 23
Colorado Springs 22
Nuremberg 21
Council Bluffs 20
Moscow 18
Mülheim 18
Brussels 17
Warsaw 17
Helsinki 16
Zhengzhou 15
Jakarta 14
Brooklyn 13
Hanoi 13
Chicago 12
London 12
Menlo Park 12
Mountain View 12
Frankfurt am Main 11
Redondo Beach 11
Phoenix 10
Redwood City 10
Stockholm 10
Tokyo 10
Brno 9
Denver 9
Florence 9
Montreal 9
Columbus 8
Guangzhou 8
Seoul 8
Boardman 7
Boston 7
Chennai 7
Falls Church 7
Lappeenranta 7
Magenta 7
Atlanta 6
Johannesburg 6
Mexico City 6
Orem 6
Palo Alto 6
Rio de Janeiro 6
San Francisco 6
Vienna 6
Brasília 5
Cedarhurst 5
Dong Ket 5
Mumbai 5
Norwalk 5
Olomouc 5
Tashkent 5
Toronto 5
University Park 5
Amsterdam 4
Belo Horizonte 4
Binasco 4
Cagliari 4
Camaçari 4
Detroit 4
Kunming 4
Lima 4
Manaus 4
Manchester 4
Ribeirão Preto 4
Saint Petersburg 4
San Mateo 4
Sumaré 4
Turku 4
Verona 4
Bologna 3
Totale 12.129
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 555
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 510
Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso 481
Virologic correlates of adherence to antiretroviral medications and therapeutic failure 480
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 469
MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases 468
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 467
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 463
Macrophages and HIV infection: Therapeutical approaches toward this strategic virus reservoir 452
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 451
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors 450
Population variation analysis at nine loci containing expressed trinucleotide repeats 449
Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso 448
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy 422
Incomplete APOBEC3G/F neutralization by HIV-1 Vif mutants facilitates the genetic evolution from CCR5 to CXCR4 usage 422
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme 416
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure 413
Dynamics of NRTI resistance mutations during therapy interruption 413
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy 410
Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir 404
Temporal change in the use of genotypic resistance testing over the years 1999--2003 394
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients with Acute Hepatitis B 393
Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors 387
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy 384
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children 370
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 361
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 290
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 235
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 205
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 185
Establishment of a Seronegative Occult Infection With an Active Hepatitis B Virus Reservoir Enriched of Vaccine Escape Mutations in a Vaccinated Infant After Liver Transplantation 140
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 128
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 118
Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study 103
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 95
Characterization of HBV and HCV minority quasispecies by ultra-deep pyrosequencing analysis: impact on pathogenicity and response to antiviral drugs 95
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 95
HHV-8 genetic diversification and its impact on severe clinical presentation of associated diseases 93
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. 85
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 83
SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021 83
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 77
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 76
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 68
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 68
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario? 66
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies 65
First National Prevalence in Italian Horse Population and Phylogenesis Highlight a Fourth Sub-Type Candidate of Equine Hepacivirus 61
Genetic heterogenicity of HIV-1 protease in drug-naive and drug-treated HIV-positive patients 58
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects 57
Factors predictive of multinucleoside analogue-resistance mutations in an unselected cohort of HAART-failed patients. 54
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy 54
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 51
Factors predictive of virological response after genotyping resistance test (GRT): data from an unselected cohort 50
Cross-resistance among NNRTIs: evaluation of the option of recycling Efavirenz after Nevirapine failure 46
The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy 41
Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-naïve individuals initiating second-generation integrase inhibitors 39
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status 39
Using a database of genotype resistance tests to describe characteristics related to detection of the multinucleoside resistance-associated Q151M mutation. 37
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era 35
Identification of the Minimal Conserved Structure of the HIV-Reverse Transcriptase under the Presence and Absence of Drug Pressure 34
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 32
Temporal characterization of frequency of drug-resistance associated mutations in the HIV-1 protease and reverse transcriptase 32
Time to detection and loss of M184 genotypic mutation among HIV patients treated with 3TC and failing an HAART regimen 29
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation 28
Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors 28
Long-term evaluation of the effect of genotype-based antiretroviral therapy upon virological, immunological, and clinical parameters 27
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units 26
null 3
Totale 14.646
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021867 0 0 0 0 0 207 268 183 39 69 69 32
2021/2022570 42 45 33 36 20 35 26 25 123 45 24 116
2022/2023895 77 66 52 88 47 131 38 224 51 69 41 11
2023/2024323 55 5 27 16 30 85 7 11 12 18 3 54
2024/20251.647 75 357 177 144 43 80 170 76 164 131 100 130
2025/20261.324 309 121 277 311 264 42 0 0 0 0 0 0
Totale 14.646